**Background:** Since the emergence of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in 2012 in the Arabian Peninsula, many questions remain on modes of transmission and sources of virus. The MERS-HCoV causes severe respiratory illness. The epidemic origins are uncertain but it is probably a zoonosis. The reservoirs could be the bat or the camel. In 2015-04-29, the MERS-HCoV is responsible of 1110 laboratory confirmed cases and 442 deaths (WHO). In outbreak situations, especially with emerging organisms causing severe human diseases, it is important to develop quickly a test to detect the virus involved. bioMérieux developed a real time PCR assay for the rapid detection of MERS-HCoV combining specific primers, probe and a RNA internal control ready-to-use premix. The results of the analytical sensitivity, the precision determination and the exclusivity study are presented.

**Methods:** A set of primers and probe (Mers-hCoV primers r-gene^®^ \#20-010 and Mers-hCoV probe r-gene^®^ \#20-011, bioMérieux) were designed on the S gene, coding for the spike structural protein. This set was evaluated in combination with a ready-to-use premix for RNA internal control to constitute a duplex RT PCR assay. The internal control, added before the extraction step, allows to check simultaneously extraction efficiency and presence of inhibitors. Extractions were performed on NucliSENS^®^ easyMAG^®^ (bioMérieux) followed by amplifications on 7500 Fast Real-Time PCR System (Applied Biosystems^®^). The analytical sensitivity was performed on 20 replicates of a wide dilution range of In Vitro transcripts. The precision determination was determined on 18 replicates of 3 points corresponding at 40, 20 and 8 times LoD 95%. The exclusivity study was carried out on major human respiratory viruses.

**Results:** The analytical sensitivity was determined by Probit analysis (MiniTab). The LoD (95% hit rate detection) was 2.89 log copies/mL of In Vitro transcripts. The coefficients of variation obtained in the precision test were ranged between 1.28% and 2.26% for the MERS-HCoV and between 1.95% and 2.39% for the internal control. The exclusivity study was performed with the major human respiratory viruses including other human coronaviruses, and no cross-reaction was observed.

**Conclusion:** The high quality in analytical sensitivity (2.89) and robustness (1.28--2.39%) were demonstrated. The combination of the MersCoV primers and probe in association with the RNA internal control ready-to-use premix provides a useful tool for the detection of MERS-HCoV virus.
